First human tests begin for new eli lilly drug
NCT ID NCT06690996
Summary
This is an early safety study to see how healthy people tolerate a new drug called LY4005130. Researchers will give the drug as an injection under the skin or into a vein and closely monitor for side effects. They will also take blood samples to measure how much of the drug gets into the bloodstream and how long it stays in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fortrea Clinical Research Unit
Dallas, Texas, 75247, United States
Conditions
Explore the condition pages connected to this study.